Paper23537372
UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines.
Wu G and 4 others. BMC Cancer, 2013. Cited by 39 papers, by iCite.
Cite this record
ConductScience Library. UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines. Papers, record 23537372. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23537372
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Cycle Checkpoints | Major topic |
| Cyclin-Dependent Kinase Inhibitor p21 | Major topic |
| Protein Serine-Threonine Kinases | Major topic |
| Signal Transduction | Major topic |
| Staurosporine | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| cdc25 Phosphatases | Major topic |
| Antineoplastic Agents | |
| Carcinoma, Hepatocellular | |
| Cell Line, Tumor | |
| Cell Movement | |
| Cell Proliferation | |
| Checkpoint Kinase 2 | |
| Humans | |
| Inhibitory Concentration 50 | |
| Liver Neoplasms | |
| Protein Kinase Inhibitors |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9743293 | Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors. | Br J Cancer | 1998 | https://conductscience.org/library/papers/9743293 | PubMed |
| 2 | 9108451 | G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells. | Cancer Res | 1997 | https://conductscience.org/library/papers/9108451 | PubMed |
| 3 | 8667426 | UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. | J Natl Cancer Inst | 1996 | https://conductscience.org/library/papers/8667426 | PubMed |
| 4 | 9815601 | UCN-01 in ovary cancer cells: effective as a single agent and in combination with cis-diamminedichloroplatinum(II)independent of p53 status. | Clin Cancer Res | 1997 | https://conductscience.org/library/papers/9815601 | PubMed |
| 5 | 11854549 | Molecular aspects of the mammalian cell cycle and cancer. | Oncologist | 2002 | https://conductscience.org/library/papers/11854549 | PubMed |
| 6 | 10665655 | G1-checkpoint function including a cyclin-dependent kinase 2 regulatory pathway as potential determinant of 7-hydroxystaurosporine (UCN-01)-induced apoptosis and G1-phase accumulation. | Jpn J Cancer Res | 1999 | https://conductscience.org/library/papers/10665655 | PubMed |
| 7 | 12677151 | Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. | Ann Surg | 2003 | https://conductscience.org/library/papers/12677151 | PubMed |
| 8 | 8500222 | Enhancement of antitumor activity of mitomycin C in vitro and in vivo by UCN-01, a selective inhibitor of protein kinase C. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8500222 | PubMed |
| 9 | 17570226 | Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. | Gastroenterology | 2007 | https://conductscience.org/library/papers/17570226 | PubMed |
| 10 | 15831461 | Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage. | Mol Cell Biol | 2005 | https://conductscience.org/library/papers/15831461 | PubMed |
| 11 | 8960146 | Differing effects of staurosporine and UCN-01 on RB protein phosphorylation and expression of lung cancer cell lines. | Oncology | 1996 | https://conductscience.org/library/papers/8960146 | PubMed |
| 12 | 17287208 | Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17287208 | PubMed |
| 13 | 2141683 | p53 interacts with p34cdc2 in mammalian cells: implications for cell cycle control and oncogenesis. | Oncogene | 1990 | https://conductscience.org/library/papers/2141683 | PubMed |
| 14 | 20023427 | A role for Chk2 in DNA damage induced mitotic delays in human colorectal cancer cells. | Cell Cycle | 2010 | https://conductscience.org/library/papers/20023427 | PubMed |
| 15 | 14555233 | DNA damage-triggered apoptosis: critical role of DNA repair, double-strand breaks, cell proliferation and signaling. | Biochem Pharmacol | 2003 | https://conductscience.org/library/papers/14555233 | PubMed |
| 16 | 2267135 | Cell cycle control by p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. I. Regulation of p53 expression. | Oncogene | 1990 | https://conductscience.org/library/papers/2267135 | PubMed |
| 17 | 18212737 | G2/M checkpoint stringency is a key parameter in the sensitivity of AML cells to genotoxic stress. | Oncogene | 2008 | https://conductscience.org/library/papers/18212737 | PubMed |
| 18 | 10629089 | Molecular determinants of UCN-01-induced growth inhibition in human lung cancer cells. | Int J Cancer | 2000 | https://conductscience.org/library/papers/10629089 | PubMed |
| 19 | 15078995 | G2 checkpoint abrogators as anticancer drugs. | Mol Cancer Ther | 2004 | https://conductscience.org/library/papers/15078995 | PubMed |
| 20 | 11376563 | UCN-01 (7-hydoxystaurosporine) inhibits in vivo growth of human cancer cells through selective perturbation of G1 phase checkpoint machinery. | Jpn J Cancer Res | 2001 | https://conductscience.org/library/papers/11376563 | PubMed |
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41683473 | Bioactivity-Guided Fractionation, Characterization, and Mechanistic Insights of Anticancer Agents from Simarouba glauca DC. Leaves. | Molecules | 2026 | https://conductscience.org/library/papers/41683473 | PubMed |
| 40818990 | In vitro assessment of Moringa Oleifera leaf extract's protective impact on fibroblast cell line (WI-38) exposed to electronic cigarette liquid. | Sci Rep | 2025 | https://conductscience.org/library/papers/40818990 | PubMed |
| 39199296 | Decoding the Role of O-GlcNAcylation in Hepatocellular Carcinoma. | Biomolecules | 2024 | https://conductscience.org/library/papers/39199296 | PubMed |
| 36136528 | The Strong Anti-Tumor Effect of Smp24 in Lung Adenocarcinoma A549 Cells Depends on Its Induction of Mitochondrial Dysfunctions and ROS Accumulation. | Toxins (Basel) | 2022 | https://conductscience.org/library/papers/36136528 | PubMed |
| 35910309 | In Vitro Growth Inhibition, Caspase-Dependent Apoptosis, and S and G2/M Phase Arrest in Breast Cancer Cells Induced by Fluorine-Incorporated Gold I Compound, Ph3PAu[SC(OMe)=NC6H4F-3]. | Int J Breast Cancer | 2022 | https://conductscience.org/library/papers/35910309 | PubMed |
| 35064206 | Adeno-associated virus-delivered alpha synuclein inhibits bladder cancer growth via the p53/p21 signaling pathway. | Cancer Gene Ther | 2022 | https://conductscience.org/library/papers/35064206 | PubMed |
| 34536148 | Casein Kinase-1-Alpha Inhibitor (D4476) Sensitizes Microsatellite Instable Colorectal Cancer Cells to 5-Fluorouracil via Authophagy Flux Inhibition. | Arch Immunol Ther Exp (Warsz) | 2021 | https://conductscience.org/library/papers/34536148 | PubMed |
| 34375307 | Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis. | JCI Insight | 2021 | https://conductscience.org/library/papers/34375307 | PubMed |
| 31935877 | Pterostilbene Suppresses both Cancer Cells and Cancer Stem-Like Cells in Cervical Cancer with Superior Bioavailability to Resveratrol. | Molecules | 2020 | https://conductscience.org/library/papers/31935877 | PubMed |
| 31670863 | Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways. | Mol Oncol | 2020 | https://conductscience.org/library/papers/31670863 | PubMed |
| 30713850 | Moringa peregrina Leaves Extracts Induce Apoptosis and Cell Cycle Arrest of Hepatocellular Carcinoma. | Biomed Res Int | 2019 | https://conductscience.org/library/papers/30713850 | PubMed |
| 30665195 | Tissue-Specific Chk1 Activation Determines Apoptosis by Regulating the Balance of p53 and p21. | iScience | 2019 | https://conductscience.org/library/papers/30665195 | PubMed |
| 30552542 | ADAM28 dramatically regulates the biological features of human gingival fibroblasts. | Odontology | 2019 | https://conductscience.org/library/papers/30552542 | PubMed |
| 30446676 | Safranal induces DNA double-strand breakage and ER-stress-mediated cell death in hepatocellular carcinoma cells. | Sci Rep | 2018 | https://conductscience.org/library/papers/30446676 | PubMed |
| 30108746 | ATM, ATR, CHK1, CHK2 and WEE1 inhibitors in cancer and cancer stem cells. | Medchemcomm | 2017 | https://conductscience.org/library/papers/30108746 | PubMed |
| 29348843 | Actein induces autophagy and apoptosis in human bladder cancer by potentiating ROS/JNK and inhibiting AKT pathways. | Oncotarget | 2017 | https://conductscience.org/library/papers/29348843 | PubMed |
| 27911270 | SAHA and/or MG132 reverse the aggressive phenotypes of glioma cells: An in vitro and vivo study. | Oncotarget | 2017 | https://conductscience.org/library/papers/27911270 | PubMed |
| 27909289 | Hyperthermia enhances 17-DMAG efficacy in hepatocellular carcinoma cells with aggravated DNA damage and impaired G2/M transition. | Sci Rep | 2016 | https://conductscience.org/library/papers/27909289 | PubMed |
| 27542250 | Drp1-mediated mitochondrial fission promotes cell proliferation through crosstalk of p53 and NF-κB pathways in hepatocellular carcinoma. | Oncotarget | 2016 | https://conductscience.org/library/papers/27542250 | PubMed |
| 26965246 | Oxidative Stress, DNA, Cell Cycle/Cell Cycle Associated Proteins and Multidrug Resistance Proteins: Targets of Human Amniotic Membrane in Hepatocellular Carcinoma. | Pathol Oncol Res | 2016 | https://conductscience.org/library/papers/26965246 | PubMed |
Genes20
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23537372
GET https://conductscience.org/api/papers/v1/23537372/references?page=2